Off label use - Label of use?

Annals of Oncology

Volumn 14, Issue 1, 2003, Pages 1-5

  Boos, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CHLORAMPHENICOL; CYTOSTATIC AGENT; DIAMORPHINE; DIETHYLSTILBESTROL; GEMCITABINE; METHOTREXATE; PACLITAXEL; SULFAMETHOXAZOLE; THALIDOMIDE; TOPOTECAN;

BODY WEIGHT DISORDER; BREAST CANCER; CHILDHOOD CANCER; CLINICAL TRIAL; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG INDUSTRY; DRUG INFORMATION; DRUG LABELING; DRUG MARKETING; DRUG QUALITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EDITORIAL; FOOD AND DRUG ADMINISTRATION; GOOD CLINICAL PRACTICE; GOVERNMENT; HUMAN; KAPOSI SARCOMA; KIDNEY DISEASE; LICENSING; LIVER DISEASE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DECISION MAKING; MEDICOLEGAL ASPECT; OVARY CANCER; PANCREAS CANCER; PATIENT CARE; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

ANTINEOPLASTIC AGENTS; DRUG APPROVAL; DRUG LABELING; DRUG THERAPY; DRUG UTILIZATION; HUMANS; LEGISLATION, DRUG; NEOPLASMS; PHARMACEUTICAL PREPARATIONS;

EID: 0037246788     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg035     Document Type: Editorial

References (23)

1. Conroy S, Newman C, Gudka S. Unlicensed and off label drug use in acute lymphoblastic leukaemia and other malignancies in children. Ann Oncol 2003; 14: 42-47.
2. Turner S, Gill A, Nunn T et al. Use of "off label" and unlicensed drugs in paediatric intensive care unit. Lancet 1996; 347: 549-550.
3. Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ 1998; 316: 343-345.
4. McIntyre J, Conroy S, Avery A et al. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child 2000; 83: 498-501.
5. Conroy S, Choonara I, Impicciatore P et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ 2000; 320: 79-82.
6. Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999; 80: F142-F145.
7. Turner S, Nunn AJ, Choonara I. Unlicensed drug use in children in the UK. Paediat Perinatal Drug Ther 1997; 1: 52-55.
8. Bücheler R, Schwab M, Mörike K et al. Off label prescribing to children in primary care in Germany: retrospective cohort study. BMJ 2002; 324: 1311-1312.
9. Lifshitz M, Gavrilov V, Gorodischer R. Off-label and unlicensed use of antidotes in paediatric patients. Eur J Clin Pharmacol 2001; 56: 839-841.
10. Essential Drugs and Medicines Policy (EDM). WHO [on-line] 2002; http://www.who.int/medicines/ (November 2002, date last accessed).
11. Cohen PJ. 'Off-label' use of prescription drugs: legal, clinical and policy considerations. Eur J Anaesthesiol 1997; 14: 231-235.
12. Henry V. Off-label prescribing. Legal implications. J Leg Med 1999; 20: 365-383
13. Burgardt C. Off-Label-Use of drugs in the GKV. Forum 2002; 17: 24-26.
14. International Conference on Harmonization. [on-line] 2002; http://www. ich.org (November 2002, date last accessed).
15. Better Medicines for Children. European Commission [on-line] 2002; http://pharmacos.eudra.org/F2/pharmacos/medchild.htm (November 2002, date last accessed).
16. Guidance for industry. Pediatric oncology studies, in response to a written request. Food and Drug Administration-Center for Drug Evaluation and Research [on-line] 2001; http://www.fda.gov/cder/guidance/ 3756dft.htm (November 2002, date last accessed).
17. Food and Drug Administration Modernization Act of 1997. Food and Drug Administration-Center for Drug Evaluation and Research [on-line] 1997; http://www.fda.gov/cder/guidance/105-115.htm (November 2002, date last accessed).
18. Reh M. Changes at FDA may speed drug approval process and increase off-label use. J Natl Cancer Inst 1998; 90: 805-807.
19. Choonara I, Conroy S. Unlicensed and off-label drug use in children: implications for safety. Drug Saf 2002; 25: 1-5.
20. Steinbrook R. Testing medications in children. N Engl J Med 2002; 347: 1462-1470.
21. The Orphan Drug Act. U.S. Food and Drug Administration [on-line] 2001; http://www.fda.gov/orphan/oda.htm (November 2002, date last accessed).
22. Press release: 1st EMEA workshop with health professionals and academia on orphan medicinal products. The European Agency for the Evaluation of Medicinal Products [on-line] 2002; http://www.emea.eu. int/pdfs/human/comp/003402.pdf (November 2002, date last accessed).
23. Best Pharmaceuticals for Children Act. U.S. Food and Drug Administration [on-line] 2002; http://www.fda.gov/opacom/laws/pharmkids/contents.html (November 2002, date last accessed).